A method is described by which the time-course of thrombin generation in plasma can be obtained from a continuous optical density recording of p-nitroaniline (pNA) production in a 2:3 diluted plasma. A chromogenic substrate, methylmalonyl-methylanalyl-arginyl-pNA (SO 68), is used that is specifically split by thrombin but at a low rate. The thrombin that appears and disappears in the plasma does not split more than 5% of the substrate added, so the rate of substrate conversion is in good approximation proportional to the amidolytic activity in the plasma over the entire period of thrombin generation. The course of the enzyme concentration can be calculated from the amidolytic activity curve. It is shown that the thrombin generation curves obtained in this way are essentially identical to those obtained via the classical subsampling method.
Introduction
The thrombin generation curve (TGC), i. e. the course of appearance and disappearance of thrombin in triggered plasma, gives information on the process of blood coagulation that is difficult to obtain otherwise. lts determination requires repeated Correspondence to: Dr. H C Hemker, Departmcnt of Biochemistry, Univ of Limburg, Postbus 676, 6200 MD Maastricht, The Netherlands subsampling from the activated plasma sample which, even when automated as far as possible, requires intensive experimentation and is not suited for routine use (1) (2) (3) .
Optical registration of a signal from thrombin-related amidolytic activity in defibrinated plasma is in principle possible by recording product formation from a chromogenic thrombinsubstrate added to the plasma. Current substrates are unsuitable, however, because they will be exhausted long before thrombin generation is over, even when added at the highest concentration that is practically possible. A slow reacting thrombin substrate will therefore have to be used, i. e. the turnover (ft.",) of this substrate by thrombin has to be low.
It is inherent to the presence of a chromogenic substrate that the physiological reactions of thrombin are interfered with. The substrate will act as a competitive inhibitor of reactions in which thrombin partakes. In order to minimize inhibition, the substrate should be present at a concentration that is far from saturating the enzyme. By definition the enzyme is half saturated if the substrate concentration equals the Michaelis constant (K",). The concentration in the experiment therefore should be below K-. On the other hand the total amount of substrate converted should remain small as compared to the initial amount present, so that the inhibitory effects remain constant during the experiment. This means that relatively high substrate concentrations are required that however remain below K-, hence K-should be high.
In this article we show that methylmalonyl-methylalanylarginyl-p-nitroaniline (SO 68) is a substrate with kinetic properties that allow continuous registration of thrombin activity. The turnover is low, but high enough to generate a well measurable signal, even though only a small fraction of the initial amount of substrate is consumed during the experiment. The inhibitory effect on prothrombin conversion remains small.
In clotting plasma, conversion of a chromogenic thrombinsubstrate is caused by two different molecular species: free thrombin and the thrombin-o2 macroglobulin complex (or Mthrombin) (1, 2) . We will show that the optical density tracing of p-nitroanilide production can be dissected mathematically in two parts, the one due to the action offree thrombin and the other to that of 02 macroglobulin-thrombin. The thrombin-dependent curve shows a steady end-level, which represents the total amount of chromogenic substrate that has been converted by free thrombin during the experiment. This amount is proportional to the amount of any other (physiological) substrate that thrombin generated in that sample can potentially split. It is a direct indicator of the amount of enzymatic "work" that thrombin can carry out during its lifetime in the activated plasma sample. Thrombin acts on a great variety of physiological substrates, to the general effect of making it the pivotal enzyme in haemostasis and thrombosis. The amount of enzymatic thrombin-action that can potentially be triggered in a given plasma is therefore likely to be a parameter to indicate the thrombin-mediated anti-bleeding and/or prothrombotic capacity of that plasma. We call this value the experiment and uninterpretable optical signals are the result The fibrin formed was discarded by centrifugation (10 min, 5,000 x g' 4" C) or by winding it on a small plastic spatula. The concentrations of factors II, VII, VIII, IX, X, XI and XII did not significantly change by the reptilase treatment (1) .
ln order to obtain a plasma in which the kinetic constants of SQ 68 could be determined directly, heated defibrinated plasma was prepared by leaving defibrinated plasma at 60' C for 60 min Any precipitate that formed was removed by centrifugation for 10 min at 10,000 x 8. It was checked that thrombin-or factor Xa added to this preparation did not loose activity in the course of 30 min Heparin contalning plasma samples were obtained from volunteers that received subcutaneously either 5,000 units of unfiactionated heparin or 40 mg of Enoxaparin or 1 mg/kg body weight of Enoxaparin. This was done in the course of a study carried out by Dr A.-V Bendetowicz in our laboratory, that will be rcported on separately. In this article the samples are used only to compare different ways of assessing the effect of heparin on the thrombin potential
Thrombin
The euglobulin fraction fiom dcfibrinated plasma was obtained by acid precipitation at low ionic strength as described by Josso and ProuWartelle (a). The precipitate was dissolved in half the original volume of buffer A, containing 0.02 M trisodium citrate, so as to obtain a concentration of clotting factors that was not lower than that in the original plasma No inhibitor activity could be detectcd in this solution Thrombin was generated in this preparation at 37" C by addition of a trace of recombinant tissue factor and CaCl2 to a final concentration of 16 7 mM. The thrombin solution obtained was either used as such, or o-thrombin was prepared according to Pietcher et al. (5) .
Factor Xa
Factor Xa was prepared according to Mertens and Bertina (6) Manual Determination of Thrombin Generation in Plasma To 240 pl of defibrinated plasma is added 60 pl of buffer A containing SQ68 at the desired concentration Thrombin formation is started by the addition of 60 pl of a solution containing 100 mM of CaCl2 and recombinant tissue factor.
At regular intervals 10 pl samples are withdrawn and subsampled into 490 pl of buffer B containing 200 pM 52238. After about 2 min the reaction is stopped with 300 pl of 1 M citric acid The moment of sampling and stopping dircctly are recorded on a personal computer with pushbutton-equipped pipettes The cuvettes are read at 405 nm in a double wavelcngth (405-546 nm) dedicated instrument prepared in our workshop, using a personal computer for data recording. For full details on the method sce ref 1.
Decay Constants of Thrombin in Plasma
To 120 pl of defibrinated plasma and 40 pl of buffer A, at 37' C, 10 pl of a thrombin preparation were added so as to obtain a final concentration of 100 nM. At suitable intervals (5-10 s) 10 pl samples were drawn and tested for thrombin as described above Thc amidolytic activities (C,) were fitted to the three parameter curve Ct: C* + (Co -C-) . e k r, where k is the decay constant (ft6..), C6 is the initial amidolytic activity and C-is the residual, steady end-level activity due to the o2 M-thrombin complex In our hands, the standard error of a single estimation is below 7To aslong as half life times exceed 4 s (k,1"" : 10 min-l) At shorter half life times it increases proportionally with t6"", with about 1olo per min I
The decay constant that is obtained in this way is the sum of the decay constants of the reaction of thrombin with the different inhibitors of plasma We distinguish k2,the u2 macroglobulin-dependent constant and /.1, that governs the non-o,2 macroglobulin-dependent reactions, principally (-85%) AT III. We calculated k2 fiom the relation k2 f : (C-lcd k6"" (where f : 0.763, i e. the ratio of the amidolytic activity of aequimolar amounts of o2 M-thrombin and thrombin, or the ratio of their ft.u, values; see refs. I and 2 and Thble 1). Alternatively k2 ' f can be estimated directly from the optical density traces as described in the annexe -o)464lb121416
Time (min) Fig. 1 the thrombin potential (TP). With the aid of the method described here the TP can be easilv determined.
Materials and Methods

Materials
Methylmalonyl-methylalanyl-arginyl-pNA (SO 68) was synthesized by Serbio Laboratories, France (European Patent 88400304.7).
The chromogenic substrate used for thrombin estimation in subsamples was H D-Phe-Pip-Arg-PNA (52238) from KABI, Sweden
Reptilase was obtained from Laboratoires Stago (Asnidres, France), a solution was made according to the instructions of the manufacturer.
As a trigger for coagulation we used relipidated recombinant tissue factor (a kind gift of Dr Yale Nemerson, Mount Sinai, New York City, USA), suppticd with 1 5 pM phospholipid (20% phosphatidylserine, 80% phosphatidylcholine) diluted so as to give a peak of -250 nM thrombin in normal plasma Buffer A contains 0.05 M Tiis-HCl at pH 7 35, 0.1 M NaCl, 0.5%" bovine serum albumin. Buffer B is identical but at pH 7 9 and contains in addition 20 mM EDTA Plasma Blood from healthy donors was collected on 0 13 M trisodium citrate; nine parts of blood to one part of citrate solution A first ccntrifugation was performed at 900 x g, at 15" C for 15 min A second centrifugation was done for 15 min at 15'C and 10,000 x g. PPP was pooled from at least 10 donors and a third centrifugation was carried out at 4' C, fot t h at 23,000 x g, this plasma was stored at -80" C. It was checked that the clotting factors and the antiproteases were in the normal range.
All thrombin generation experimcnts were carried out in defibrinated plasma, that was obtained by mixing an aliquot of plasma with 1:50 volume of a reptilase solution, letting a clot form for 10 min at 37' C and keeping the clotted plasma at 0'C for 10 min It is good to occasionally check that the reptilase-induced clotting time of normal plasma is around 300 s. If it is substantially longer than the reptilasc solution has lost activity and incomplete defibrination may result. Clot formation during We determined the kinetic constants of a number of different substrates under conditions as close as possible to those under which we wanted to use them, i. e. in2:3 diluted plasma. In order not to be hindered by thrombin inactivation the antithrombin activity was abolished by heating for 60 min at 60' C. We selected SQ 68 as the one which was converted by thrombin sufficiently slow, and yet was sufficiently specific for thrombin Table 1 gives the kinetic constants of this substrate.
In order to get an impression of what substrate concentrations should be used, we mathematically simulated substrate conversion in a plasma in which thrombin is generated. As input we used the three variables: initial substrate concentration, Michaelis constant (K-) and catalytic constant (k"",) of the splitting of the substrate by thrombin and a typical thrombin generation curve in normal plasma after triggering with thromboplastin (mean of 5 curves). The program calculated the velocity of substrate conversion according to the classical formula rt : k"ut. Er . Sr/(K-+ Sr). (The subscripts r indicate the variable at time t, so E, is the amount of thrombin as given by the thrombin generation curve, S, is the amount of substrate remaining at time l.) Then the apparent E,' was calculated as in an actual experiments, i. e. by calculating Er' : v, . (K-+ .S6)/k"ut . Se. In this formula Ss replaces S,, so that E,' is an approximation of the real E,.
From the results obtained it can be seen ( Fig.1 , curve C) that at SQ 68 concentrations of 25 pM the course of E, so calculated already fits closely to the actual thrombin generation curve. A conventional substrate would only render the first part of the TGC, even when added at impracticably high concentrations (curves A and B).
The presence of a thrombin substrate in plasma, slows down the action of antithrombins because they act on free thrombin only and not on the thrombin-chromogenic substrate complex. This makes that in actual practice the results with conventional substrates would be even worse than suggested by the simulation experiments. Even if we double the thrombin values of the normaf atwe,25 pM of SQ68 would still give a line hardly distinguishable from the actually measured points (results not shown).
From these simulation experiments it is clear that a substrate with the kinetic properties of SQ 68 will theoretically indicate correctly the amount of free thrombin present when it is added at concentrations of 25 pM and higher. In order to obtain a sufficiently high signal considerably higher concentrations are used in practice (see below).
The kinetic constants of SQ68 with thrombin, o,2 M-thrombin and factor Xa as a substrate are shown in Thble 1.
Continuous Registration of the Thrombin Generation Curve
In a disposable plastic semi-microcuvette we added 400 pl of defibrinated plasma, 100 pl of buffer A, to which substances to be tested (heparin e. g.) can be added and 60 pl of a solution of SQ68 so as to obtain the required final substrate concentration (200-1,000 pM). The reaction was started at zero time by adding 40 pl of recombinant tissue factor in 0.25 M CaCl2. The reagents were prewarmed to 37'C and the cuvette was thermostated at that temperature during the measurement.
The optical density at 405 nm was recorded at the pace of 2 measurements per second (Fig.2) . We calculated the average of the first derivative of the OD trace at every 24 measuring points, i. e. over 12 s intervals (Fig 3, upper frame) . From the substrate conversion velocities so obtained we calculated the enzyme conditions via the classical formula dS/dr : k.ur. E . S/(K,, + S) (Fig.3, lower frame) .
We also determined manually the course of thrombin activity in identical reaction mixtures, including different concentrations of SQ68, by subsampling at 12 s intervals in cuvettes with the usual thrombin substrate 52238 (Fig.4) . Different concentrations of SQ68 were included in order to register its effect on the coagulation system. From parallel blank experiments it was seen that the SQ 68 in the reaction mixture did not add more than 2 mOD (equivalent to about 0.1 nM thrombin) to the signal in the subsamples, so that the signal obtained could be interpreted in terms of splitting of 52238. Comparison of the manual data and those obtained from the continuous registration showed acceptable resemblance (Fig. 4) . Influence of SQ68 on Thrombin Inactivation From Figs.3 and 4 it is seen that both in the continuous and in the manual experiments the presence of SQ68 causes an increase of the €imount of thrombin measured. This is to be expected because the substrate competes for the active centre of thrombin with the natural thrombin inhibitors, such as antithrombin III. Whether o,2 macroglobulin-mediated thrombin inactivation also is influenced is open, because this inhibitor leaves the active centre of thrombin free, at least in the final complex. We determined the AI III and 02 M-dependent decay constants of thrombin in the presence of different concentrations of SQ 68 (Table 2 ). lt is seen that both constants are decreased by SQ 68 and that l/fd.. increases linearly with the SQ68 concentration (Fig.5) .
Influence of SQ68 on Prothrombinase
With the decay constants of Thble 2 we can calculate the course of the velocity of prothrombin conversion, i. e. the course Fig. 6 . It is evident that significant inhibition of prothrombinase activity only appears at the higher (>1,000 pM) concentrations of SQ 68.
Comparison of Inhibitions Found with the Old and the New Method
In order to compare the continuous and the subsampling method as to their susceptibility to inhibition, we detcrmined the inhibition of the area under the TGC, i. e. the thrombin potential, brought about by different amounts (0.01-0.1 U/ml) of unfractionated heparin both with the subsampling method and with the continuous method (Fig.7) . A good correlation is found between the two methods.
The a2 Macroglobulin-thrombin Complex as an Indicator of the Tp
It did not escape our attention that plasma contains a natural pseudo-substrate of thrombin that is not exhausted during the B Time (min) Fqq 9 Mathematical dissection of the optical density trace from pnitroaniline production from SQ68 in clotting plasma. A: Original OD tracing; B: contribution of the o2 macroglobulin-thrombin complex; C: contribution of free thlombin; TP: amount of substratc cventually converted by free thrombin, i. e steady level of C clotting process, i. e. o,2 macroglobulin. This inhibitor reacts with thrombin to form the or macroglobulin-thrombin complex. The complex conserves the amidolytic activity of thrombin against small substrates and by this activity can be easily assessed. The amount of the complex eventually formed, is dependent upon the initial concentration of u,2 macroglobulin, and to the thrombin potential. Because the concentration of o2 macroglobulin in a given sample is subject to variation, measuring of the product, i. e. the a2 macroglobulin-thrombin complex after coagulation is not a substitute for me asuring the TP with chromogenic substrate, yet an impression of the TP value can be obtained in this way. Fig.8 shows that there is a good correlation between the TP calculated and the residual, o,2 macroglobulin-thrombin dependent, amidolytic activity after coagulation (l : 0.95).
Discussion
The chromogenic substrate, methylmalonyl-methylalanyl-arginyl-pNA (SO 68) has kinetic propertics that allow the entire course of thrombin-related amidolytic activity in triggered plasma It has been proposed to calculate the decay constant of thrombin directly from the optical density trace obtained in a mixture of AT III, thrombin and Tos-Gly-Pro-Arg-pNA (9) . This is possible only if the concentration of the decay-inhibiting chromogenic substrate remains constant during the course of thrombin decay. ln the experiments of ref. 9 up to 34"/o of the substrate is consumed, so that the inhibition of thrombin decay constant will vary considerably and continuously during the experiment. This considerably complicates the evaluation of the curves. Preliminary experiments show that this complication is not encountered with SQ 68.
It is not immediately clear whether the o2 macroglobulin dependent decay constant (k2) should be influenced by the presence of the chromogenic substrate, because the mechanism of action of this inhibitor is not that of a pseudo substrate (10) . In Fig. 5 we see that the inverse of the decay constants varies linearly with the concentration of substrate, i. e that the inhibition is competitive. This may be caused by the fact that, even though in the final enzyme-inhibitor complex the active centre of thrombin is free, the first step in inhibition by o,2 macroglobulin is proteolytic cleavage of the "bait" region of the inhibitor (10) .
From the amidolytic activity curves we calculated the velocity of prothrombin conversion according to refs. 1. and 2, using k1 and k2 as obtained in the presence of SQ68 (Fig.6 ). Prothrombin conversion is significantly inhibited only at SQ68 concentrations of 1,000 pM and higher. With low SQ68 concentrations the experimental noise tends to be important (dotted lines in Fig.3 ). We choose 500 pM as a compromise. We think that in SQ68 we have obtained a reasonably good substrate for continuous registration of the amidolytic activity. The ideal would be an entirely specific thromtiin-substrate with a still higher K,,, so that few thrombin would be occupied in enzyme-substrate complexes and the substrate would interfere minimally with other thrombin substrates.
The nearly constant amount of SQ68 present in the experiments acts as a competitive inhibitor on all other reactions in which thrombin is involved. This does not seem to alter imoortantly the relations within the clotting mechanism. At least the inhibition brought about by heparins is not significantly influenced by the presence of SQ68 (Fig.7) .
Calculation of the Thrombin Generatictn Curve and the Thrombin Potential (TP) Fig. 1 shows the general form of a thrombin generation curve as it is known from previous work. The amidolytic activity measured is caused by the simultaneous activity of thrombin and the o2 macroglobulin-thrombin complex. The latter builds up during the test with a velocity proportional to the amount of free thrombin available (1). It is responsible for the thrombinlike amidolytic activity found in serum, i. e. for the non-zero end-level of the TGC. In TGCs that are determined with fibrin as the substrate for the thrombin in the subsamples, this phenomenon is not seen because n2 M-thrombin does not act on fibrin (11) . A simple mathematical treatment of the data allows to obtain the course of free thrombin from the amidolytic activity curve if we know k2 . f, i.e.the pseudo-first order constant of the interaction between o,2 macroglobulin and thrombin (fr2) multiplied by I the ratio of the ft"o1 of a,2 macroglobulin-thrombin over the k"u, of thrombin (1, 2). The introduction of the constant / in the calculations accounts for the difference between k"u, of free thrombin and u2 macroglobulin-thrombin. The differences between K-are not accounted for but the error that is thus introduced remains below 2.57". A calculation analogous to that giving the thrombin curve from the amidolytic activity curve can be carried out on the experimental OD trace (Fig 9A) Inhib -Inhibition of prothrombin conversion. Cons -Percentage of the initial SQ 68 concentration consumed in 10 min to be followed in a spectrophotometer The reaction velocity of substrate conversion can be obtained in real time from the first derivative of the OD-tracing. It is in good approximation proportional to the amidolytic enzyme activity because maximally 8% of the substrate is consumed during the first 10 min of the reaction The proportionality factor is obtained from classical enzyme kinetics: E : v (K^ + S)//."ut . Ss. Fig.4 shows that indeed in practice the curves found by the automatic method are acceptably near to those obtained by the manual method.
The effect of substrate consumption can be accounted for mathematically and exact determination of enzyme activity is readily possible when higher precision is required or if other substrates would be employed (see annexe). Yet it is important that the substrate concentration should not diminish too much during the experiment because it is preferable that any inhibitory effects of the chromogenic substrate remain constant during the experimen[ (see below).
The technique thus faithfully renders the time course of the amidolytic enzyme concentration. The next question is in how far the presence of SQ68, influences this course.
Influence of SQ68 on the Amidolytic Activity Curve, Selection of a Suitable Substrate Concentration Part of the amidolytic activity must be attributed to factor Xa because of the relatively high turnover-number of SQ 68 with that enzyme (Table 1 ). This is counteracted by the high K-, which also assures little inhibition of physiological factor Xa activity by the substrate. Indeed no important inhibition of prothrombinase activity is found (Fig. 6) . The peak activity of factor Xa in clotting plasma is around 10 nM (7). With the kinetic constants of Thble 1 one can calculate that this amount of factor Xa will cause a oNA production that, at a SQ68 concentration of 500 uM, is lesJthat 10Y" of that of the peak activity of thrombin.
AT Ill is a pseudosubshate that attacks the active centre of thrombin. A chromogenic substrate will compete with AT III for this active centre and therefore compctitively inhibits AT III action (8) . Frorn standard enzymology it follows that, because the ATIII (-2.5 pM) and the SQ68 (>100 pM) are in excess over the thrombin (<200 nM), the pseudo first order constant of AI III dependent thrombin decay (fr1) in good approximation decreases by a factor K-l(K-+ S) (S : substrate conccntration, K-: Michaelis constant). This explains why increasing concentrations of SQ 68 cause increasing amounts of thrombin to be generated (Figs.3 and 4) Because the concentration of SQ 68 hardly diminishes during the experiment, its effect on the decay of thrombin is essentially constant. The effect of an additional inhibitor, like heparin, remains unaltered when expressed as a percentage of an uninhibited control (Fig.7) . allows to dissect the OD development due to the action of the free thrombin (Fig.9C ) from the OD generated by o2 M-thrombin (Fig.9B, see further annexe ). The steady end-level of the thrombin-trace represents the thrombin potential.
The k2 term implicitly incorporates the o2 macroglobulin concentration, in fact the plasma to plasma variations of t2 must be attributed to variations in o2 macroglobulin concentration. The algorithm of the annexe seeks ft2 (multiplied by the constant f) for each individual experiment and therefore eliminates this variation as a source of error. When SQ68 is used as a substrate then f :0.763.
If k2 and / have been determined before, then the colour development due to free thrombin can be calculated in real time. From this the concentration of free thrombin can be calculated. again in real time, because the reaction velocity (first derivative of the OD trace) is dependent on the thrombin concentration and a number of known constants: initial substrate concentration (56), turnover number (k"u,) and Michaelis constant (K-) (see annexe).
With an unknown plasma sample, k2 . f can be obtained from the experimental curve after the experiment is finished and the concentration curve of free thrombin can then still be calculated (see annexe). Also k2 . f can be guessed in order to obtain an approximately correct thrombin generation curve on line, that can be corrected after the experiment is finished. We reported before that k2 equals 0.232 + 0.004 min I (SEM; n : 25) (3), in the presence of 500 pM SQ68 this reduces to 0.136 min-1. This value is a safe guess unless patients are studied in which an increase of a2 macroglobulin is to be expected.
The steady end,level of the curve that represents the amount of substrate split by free thrombin (ETP in Fig. 9 ), is proportional ro the thrombin potential. Knowing the kinetic constants of Se6g we can calculate how much thrombin has been acting on the substrate and for how long. The dimension of this figure is thrombin concentration x time (i. e. nM min). The normal value of the thrombin potential is 487 + 2l nM min (n : 12) (12).
The TP directly indicates how much of any physiological substrate present in, or in contact with, the plasma can be converted by thrombin if the plasma is triggered. The Tp is identical to the time-concentration integral of the formed thrombin, i. e. the surface under the thrombin generation curve. The surface under the thrombin generation curve has been introduced very early in tests for prothrombin estimation (11, 13) . It indeed can be traced back into the 19th century (1a). In the more recent literature it is not frequently encountered, a. o. because it requires time consuming experimentation.
Use of the Thrombin Potential (TP)
The overall activity of the clotting system is usually assessed by measuring a coagulation time. This type of test comes r'n many varieties, but it always essentially measures the time that elapses until a level of 10-20 nM of thrombin is formed in the reaction mixture (15) . Spectrophotometric tests that are meant to replace clotting tests also measure the moment of onset of exolosive thrombin generation. At that moment, the peak of thiombin formation (100-300 nM) is still to come. Often, e. g. in plasma that clots via the extrinsic pathway in the presence of heparin, the lag-phase of thrombin formation is hardly prolonged even when the peak amount is significantly inhibired (2, 3) . In general it can be said that alterations of the clotting system are not always necessarily reflected in the lag-time of thrombin formation, i e. in the clotting time.
Recent research tends to stress the central position of thrombin in the pathogenesis of thrombosis (16, 17 , sei also 18 and 19 for an overview). Thrombin appears as the pivotal enzyme in haemostasis and thrombosis. Its effects are due to its action on a number ofphysiological substrates (e. g. the tethered ligand ofthe platelet membrane, fibrinogen). The magnitude of these effects is determined by the amount of substrate that thrombin converts. This amount is always proportional to the thrombin level combined with the time that the thrombin can act, i. e. to the time integral of the concentration of free thrombin, i. e. to the surface under the TGC, i e. to the TP. It is easily seen that the amount of the artificial substrate that is converted by thrombin is necessarily proportional to the amount of any physiological substrate that can be converted by this thrombin. It therefore is a direct indicator of the haemostatic-and thrombotic action that this plasma can potentially exert via thrombin.
It is our conjecture that the influence of an anticoagulant on the thrombin potential is a direct indicator of its efficiency. It therefore is important that inhibitions observed by the continuous method correlate well with those seen in the direct method (Fig 7) . Preliminary experiments indicate that the continuous method lends itself well to adaptation to a laboratory auromarlon. It may be interest to those that cannot adopt the Se 68 method that the o2 macroglobulin-thrombin level in serum is a direct indicator of the thrombin potential, be it with individual variations in o2 macroglobulin level as a confounding factor (Fig 8) . In cases where one wants to investigate the influence on the thrombin potential of inhibitors added to a plasma sample the o,2 macroglobulin level is equal in all samples and the o,2 macroglobulin-thrombin level after coagulation directly indicates inhibition of the thrombin potential relative to the control.
